Time-dependent ROC analyses highlighted that serum fCK18 levels had a consistent impact on short- to long-term survival of HCC patients, while AFP and DCP had a strong impact on the short-term survival of patients with HCC. This evidence concerns the gene ACE and hepatocellular carcinoma.